Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

Launched by VESALIO · Mar 24, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a device called NeVa VS, which is designed to help open up narrowed blood vessels in the brain. This condition, known as cerebral vasospasm, often occurs after a type of bleeding in the brain called aneurysmal subarachnoid hemorrhage (aSAH). The goal of this study is to see how well the NeVa VS device works in treating this issue in patients who are experiencing symptoms from the vasospasm.

To participate in this trial, individuals must be at least 22 years old and have symptoms of cerebral vasospasm due to aSAH affecting specific arteries in the brain. Importantly, participants will need to have a procedure done using the NeVa VS device and be able to provide consent within three days after the procedure. While the trial is not yet recruiting, it aims to gather valuable information about the effectiveness of this device in managing a serious condition that affects blood flow in the brain. If you or a loved one are considering participation, it could offer insight into a potential treatment option for this challenging condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥22
• • 2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
• • 3. Vessel dilation procedure was performed with the NeVa VS
• • 4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure
• Exclusion Criteria:
• • None